Cell line name |
TKB-6 |
Synonyms |
TKB6 |
Accession |
CVCL_S134 |
Resource Identification Initiative |
To cite this cell line use: TKB-6 (RRID:CVCL_S134) |
Comments |
Population: Japanese. |
Disease |
Lung adenocarcinoma (NCIt: C3512) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Sex of cell |
Sex unspecified |
Age at sampling |
Age unspecified |
Category |
Cancer cell line |
Publications | PubMed=2430695 Katsuyuki Endo, Hiroshi Kamma, Takesaburo Ogata; Two murine monoclonal antibodies against human lung cancer-associated antigens. Cancer Res. 46:6369-6373(1986) PubMed=2548713 Hiroshi Kamma, Katsuyuki Endo, Hisashi Horiguchi, Tatsuo Iijima, Takesaburo Ogata; Lung cancer-associated monoclonal antibody 15 that recognizes cell growth-related membrane antigens gp85/45 and its growth-inhibitory effect on human lung cancer cells in vitro. Cancer Res. 49:5118-5122(1989) PubMed=10365094; DOI=10.1002/(SICI)1096-9896(199901)187:2<191::AID-PATH206>3.0.CO;2-3 Takuya Yazawa, Hiroshi Kamma, Masachika Fujiwara, Miwa Matsui, Hisashi Horiguchi, Hiroaki Satoh, Mitsuo Fujimoto, Koichi Yokoyama, Takesaburo Ogata; Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer. J. Pathol. 187:191-199(1999) |
Cross-references |
Encyclopedic resources |
Wikidata; Q54972572
|
Entry history |
Entry creation | 05-Nov-2013 |
Last entry update | 21-Mar-2023 |
Version number | 6 |
---|